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The structural maintenance of chromosomes 5/6 (Smc5/6) complex plays a 
critical role in maintaining genomic integrity. More specifically, Smc5/6 is involved in 
DNA replication, DNA damage repair via homologous recombination (HR), and 
chromosome segregation. Although its function has been extensively studied in yeast, 
few studies have evaluated Smc5/6 in mammalian models. Based on existing literature, 
we hypothesized that Smc5/6-deficient mouse embryonic fibroblasts (MEF) would 
accumulate DNA damage and, as a result, demonstrate abnormal mitotic progression and 
show evidence of replication stress. 
 Methods:  
We used transgenic mice harboring a floxed exon 4 of the Smc5 gene (Smc5flox/flox 
and Smc5+/del, Ert2-Cretg/0 ) to breed and establish immortalized MEF cell lines with 
genotypes of Smc5flox/del, Ert2-Cretg/0 (experimental), Smc5+/flox, Ert2-Cretg/0 (control #1), 
and Smc5flox/del (control #2). Smc5 exon 4 was deleted by addition of 0.2µM 4-OH 
tamoxifen for nine days. Deletion was confirmed by PCR and protein depletion by 
western blot. Cells were analyzed on day 3, 6 and 9. 
  MEF growth characteristics and cell cycle progression were evaluated by 
performing cell counts and FACS analysis, respectively. We also used 
immunofluorescence microscopy to observe micronuclei formation and DNA bridges. 
Additionally, we analyzed Rad51, Sumo1, and Sumo2/3 after treating cells with 
hydroxyurea. Finally, we used western blot analysis to evaluate expression of the stress 





 Results:  
Smc5-depleted MEFs demonstrated several mitotic abnormalities. After six days 
of 4-OH tamoxifen treatment, we observed a sustained, two-fold decrease in cell 
proliferation compared to controls. FACS analysis showed delayed entry into S-phase. 
DAPI staining of Smc5-depleted cells showed 12% increase in micronuclei formation 
and 33% increase in DNA bridges. Hydroxyurea-treated cells showed an accumulation of 
Rad51 foci, suggesting impaired HR mechanisms. Mutation of Smc5 also resulted in a 
decline in Sumo1 but not Sumo2/3 foci. Lastly, western blot analysis showed significant 
p53 upregulation. 
 Conclusions:   
For the first time, we have demonstrated the importance of the Smc5/6 complex in 
somatic mouse cells. Smc5 depletion in MEF cells compromises genomic integrity, 
affects cell cycle progression and leads to chromosome missegregation. We also 
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 Structural Maintenance of Chromosomes (SMC) proteins 
The structural maintenance of chromosomes (SMC) proteins form a highly 
conserved group of complexes that play a key role in maintaining cell genomic integrity. 
SMC proteins are involved in essential chromosome-based processes, such as sister 
chromatid cohesion, chromosome condensation, and chromosome segregation. 
Additionally, SMC proteins have been found to play roles in DNA replication, DNA 
damage repair, and transcription (T. Hirano, 2006).    
The SMC proteins interact with one another to form a V-like structure. In 
eukaryotes, there are six SMC members that form three heterodimeric protein complexes: 
cohesin (Smc1/3), condensin (Smc2/4), and Smc5/6 (Figure 1). Cohesin and condensin 
are known to be involved in two major cell division events: cohesion of sister chromatids, 
and pre-mitotic chromosome compaction, respectively. Mutations in either of these 
complexes results in dramatic disruption of chromosome segregation and  causes 
genomic instability (Wu & Yu, 2012).  
Unlike cohesin and condensin, the role of Smc5/6 is less well-defined. Though 
mechanistically unclear, studies in budding and fission yeast have shown Smc5/6 to be 
involved in double-strand DNA break (DSB) repair via homologous recombination (HR)  
(De Piccoli et al., 2006), maintenance of replication fork stalling (Irmisch et al.,2009), 
and chromosome segregation (Torres-Rosell et al., 2007). Smc5 and Smc6 mutants in 
budding yeast have been shown to accumulate X-shaped DNA structures. Investigated at 
different time points, these have been associated with both damaged replication forks 
(Branzei et al., 2006) and defective chromosome segregation (Tores-Rosell et al., 2005). 





agents, (reviewed in Stephan et al., 2011), further implicating its crucial role in DNA 
damage repair. 
 
SMC complex architecture 
The SMC proteins are made up of 1,000-1,500 amino acids and compile into 
structurally similar shapes. The N and C terminals contain Walker A and Walker B 
motifs, as well as half of an ATPase head. The protein folds in half, forming an 
intermolecular coiled coil that allows the ATPase halves to combine into a single 
globular head. On the opposite end, a hinge domain facilitates heterodimerization with 
another SMC protein. Smc1 pairs with Smc3 (cohesion), Smc2 pairs with Smc4 
(condensin I and II), and Smc5 pairs with Smc6 (Potts, 2009).  
Upon heterodimerization, an SMC complex is formed. Electron microscopy 
reveals that Smc1/3 and Smc2/4 can adopt several conformations, including V-shapes 
and ring-like structures (Hirano et al., 2001) (Figure 1 B). Dimerization also allows 
ATPase heads to interact with one another and hydrolyze ATP. Although similar in 
architecture, the sequences of Smc5 and Smc6 are divergent from Smc1-4 (Beasley et al., 
2002).  
The SMC heterodimers also associate with other subunits to become a fully 
functional complex. Condensin has three subunits that interact with the head domain to 
complete the ring-like structure. Condensin I is comprised of proteins Ncaph, Ncapg and 
Ncapd2, while Condensin II interacts with Ncaph2, Ncapg2, and Ncapg3 (Wilson et al., 
2013) (Figure 1 A). Similarly, Scc1 and Scc3 interact with the cohesin head domain to 





directly with the dimer.  Nse1, Nse3, and Nse4 interact transiently with the head domain: 
Nse4 bridges the ATPase head, while Nse1 and Nse3 bind Nse4 and one another. Unlike 
these proteins, Nse2 (also known as Mms21) directly binds the arm of the Smc5 
intermolecular coiled coil (Hirano, 2006) (De Piccoli et al., 2009) (Figure 1).  
Nse1 and Nse2 have been shown to be essential for the function of Smc5/6. 
Mutations of Nse1 and Nse2 in fission yeast demonstrated phenotypes similar to the 
inactivation of the entire Smc5/6 complex (McDonald, Pavlova, Yates, & Boddy, 2003). 
Nse1 contains a RING domain with ubiquitin ligase activity, while Nse2 has a SP-RING 
domain with small ubiquitin-like modifier (SUMO) ligase activity (Potts, 2009). 
Sumoylation by Nse2 has been shown to be crucial for DNA damage repair (Wu and 

























Figure 1 (A) Architecture of Condensin I and condensin II (W. Wilson & M, 2013) and (B) cohesin and 







Mitotic role of SMC complexes 
The primary goal of mitosis is to accurately and completely duplicate genetic 
information and transmit DNA content to daughter cells. To ensure that this happens, the 
SMC proteins tightly regulate chromosome dynamics. At the onset of G1 phase, cohesin 
is activated by acetylation and recruited to establish sister chromatid cohesion during S-
phase (Ben-Shahar et al., 2008). The ring structure of cohesin encircles the two sister 
chromatids and holds them together (Nasmyth, 2011). After replication, condensin II acts 
on chromosomes during prophase while condensin I is sequestered until prometaphase. 
Condensin II and condensin I are involved in axial shortening and lateral compaction, 
respectively, to resolve sister chromatids (Shintomi and Hirano, 2011). At the onset of 
condensin II loading, cohesin is simultaneously released further promoting chromatid 
resolution by weakening physical linkages. At anaphase, cohesin is completely released 
by seperase-induced cleavage of the kleisin subunit, Scc1. A balancing act between 
condensin II, condensin I and cohesin is needed for successful chromosome segregation 
(T. Hirano, 2015) (Figure 2). 
Unlike cohesin and condensin, the role of Smc5/6 is less distinct. Smc5/6 plays a 
role from S-phase through M-phase, and is involved in both DNA damage repair and 
non-repair functions. During S-phase, Smc5/6 ensures faithful replication by promoting 
HR-mediated repair of DNA damage, but also avoiding complex recombination 
intermediates (reviewed in Murray and Carr, 2008). HR repair is essential for the repair 
of stalled replication forks and DSBs from yeast to mammals (Saleh-Gohari et al., 2005).  
Cohesin loading at the site of DNA damage is thought to promote HR by holding 





activates the protein kinases ataxia telangiectasia and Rad3-related protein (ATR) and 
Checkpoint kinase 1 (Chk1), initiating a signal transduction pathway (Smith et al., 2010). 
In budding yeast, ATR/Chk1 phosphorylates the cohesin subunit, Scc1 (Heidinger-Pauli 
et al, 2009). In turn, establishment of cohesin 1 (Eco1), an acetylatrasferase that is needed 
for sister chromatid cohesion (Ivanov et al., 2002), also modifies Scc1 via acetylation 
(Heidinger-Pauli et al., 2009). This antagonizes the wings apart-like (Wapl) protein, 
which normally binds to cohesin and facilitates cohesin removal from chromosome arms 
(Gandhi et al., 2006). Thus, displacement of Wapl promotes cohesin loading at the site of 
DNA damage (Unal et al., 2007). 
Though the mechanism is unknown, Smc5/6 is needed to maintain cohesin at 
DNA lesions (De Piccoli et al., 2006; Strom et al., 2007). In budding yeast, Smc5/6 is 
recruited by the repair factor Mre11, which accumulates early on at the site of DNA 
damage (Lindross., Strom, 2006). In human cells, Smc5/6 was shown to modulate HR via 
sumoylation of Scc1 by Nse2 (Wu and Kong et al, 2012) (Figure 3).  
In line with a role in DNA damage repair, chromatin immunoprecipitation (ChIP)-
on-chip analysis of chromosome XII in budding yeast showed that Smc6 accumulates at 
DSBs and stalled replication forks (Nasmyth, 2011). Additionally, Smc5/6 was shown to 
accumulate at centromeric regions during the G2/M-phase in undamaged cells, 
suggesting it plays a role in chromosome segregation (Lindross et al., 2006). During 
replication and HR repair, joint molecules, physical attachments, and sister chromatid 
intertwining can develop, creating a topological stress for cells. If not relieved, 
chromosome segregation is blocked (Murray et al., 2008; Jeppsson et al., 2014). In 





Top2 mutant yeast cells, Smc5/6 bound to chromosomes in a cohesin-dependent manner. 
The amount of Smc5/6 on chromosome arms was positively correlated with 
missegregation events, suggesting that Smc5/6 is needed for accurate chromosome 
segregation (Jeppsson et al., 2014). 
 
 












Smc5/6-cohesin mediated HR repair 
 
 












Smc5/6 and DNA damage repair via homologous recombination 
Several studies have associated Smc5/6 with homologous recombination. 
Induction of DNA damage using various agents (ionizing radiation, ultraviolet radiation, 
methyl methanesulfonate, hydroxyurea and etoposide) have shown an increase in mitotic 
catastrophe among Smc5/6 mutants (Wu and Yu, 2012). Three common substrates of 
homologous recombination have been studied: DSBs, stalled replication forks, and 
collapsed replication forks. Repair of all three substrates is essential as they threaten cell 
viability and genomic integrity. DSBs are among the most serious types of DNA damage 
as they can lead to lethality. Prolonged replication fork stalling and collapse can also lead 
to DSBs (Saleh-Gohari et al., 2005).  
Smc6 was shown to localize to DSBs during the G2 and M-phase (Picolli et al., 
2006, Lindross et al., 2006). Two primary types of repair mechanisms are employed to 
repair DSBs: non-homologous end joining (NHEJ) and HR. De Piccoli et al reported that 
budding yeast Smc5/6 mutants showed a four-fold decrease in DSB repair and a 100-fold 
increase in gross chromosomal arrangements. However, NHEJ repair was not affected, 
suggesting that Smc5/6 plays an exclusive role in mediating HR (De Piccoli et al., 2006). 
Homologous recombination is considered to be an error-free method of repairing 
DNA damage. The HR pathways uses the exchange of a similar DNA sequence, such as a 
sister chromatid, as a template for repair. Strand invasion of the ssDNA is mediated by 
Rad51, forming a characteristic D-loop (Li & Heyer, 2008). In fission yeast, two time-
dependent HR models were proposed for resolving stalled replication forks. During early 





conformation in order to prime forks for restart. During late replication fork stalling, 
Smc5/6 mediates resolution of DNA structures (Irmisch et al., 2009). Alternatively, DNA 
damage can also be bypassed via a HR-dependent template switch mechanism (reviewed 
in Kegel et al., 2011) (Figure 4).   
Although the role of the Smc5/6 complex during HR is still mechanistically 
unclear, ongoing studies are providing insights into how it may be working. First, Roy et 
al. showed that Smc5 and Smc6 have a higher binding affinity for ssDNA than dsDNA. 
This is an important observation because ssDNA accumulates at the initial stages of 
replication fork stalling or DNA damage. The ability of Smc5/6 to bind even small 
sections of ssDNA (~60nt), supports the idea that Smc5/6 mediates HR repair (Roy and 
D’Amours et al., 2011; Roy and Siddiqui et al., 2011). Furthermore, Smc5/6 was shown 
to bind synthetic DNA molecules that were designed to resemble structures created 
during HR. Smc5/6 efficiently bound to synthetic Holliday junctions and splayed Y 
models, suggesting that Smc5/6 plays a direct role in HR (Roy et al., 2015). 
Additionally, Nse2-deficient budding yeast were shown to accumulate X-shaped 
DNA structures at stalled replication forks. Because these accumulated in a Rad51 
dependent manner, the DNA structures are thought to be HR intermediates (Branzi et al., 
2006). Similarly, IR-induced DSBs in Drosophila melanogaster heterochromatin were 
shown to use HR repair. Smc5/6 was found to be physically associated with HP1a, a 
histone modification protein that is enriched in heterochromatin. DNA repair sites were 
shown to expand and re-localize outside of the HP1a domain, where they associate with 
Rad51. Smc5/6 recruitment was shown to preclude Rad51 formation, suggesting that 





heterochromatin (Chiolo et al., 2011). HR within heterochromatin can cause loss or 
duplication of information due to the large number of repeat sequences (Peng et al., 
2008). In further support of this model, Smc5/6 depletion caused an accumulation of 
Rad51 within heterochromatin (Chiolo et al., 2011).  
 




Figure 4 Proposed roles for the Smc5/6 complex during HR at stalled replication forks. At the onset of 
DNA lesions, Smc5/6 is involved in mediating replication fork restart, replication fork stabilization, or 









Smc5/6 and chromosome segregation 
In addition to HR-mediated repair, Smc5/6 has been proposed to play an active 
role in chromosome segregation. Post-HR, sister chromatids are held together by joint 
molecules that need to be removed for accurate chromosome segregation. If not removed 
in a timely fashion, aberrant chromosome rearrangement and breakage can occur during 
cell division.  Smc6 mutants in budding yeast were shown to accumulate sister chromatid 
junctions. Upon reactivation of Smc6, junctions were dissolved (Bermudez-Lopez et al., 
2010). Similarly, NSE2 mutant human cells were shown to be hypertensive to UV 
exposure, and accumulated sister chromatid exchanges (Payne et al., 2014).  
A segregation analysis of chromosome XII in budding yeast showed evidence of 
unequal division of centromeres in Smc5/6 mutants. It was suggested that unresolved 
linkages enriched at the centromeric regions lead to chromosome nondisjunction (Torres-
Rosell et al., 2007) (Figure 5). Chromosome missegregation has also been observed in 
human cells. Staining with CREST, a kinetochore marker, showed unequal centromere 
division in Smc5/6 mutant daughter cells. Additionally, DAPI staining and 
immunostaining for BLM and PICH revealed lagging chromosomes and DNA bridges 
(Gallego-Paez et al., 2013). 
Lastly, mitotic failure in fission yeast Smc5/6 mutants has also been associated 
with sustained cohesin on chromosome arms. Cohesin localization was analyzed by ChIP 
using Rad21-GFP in hydroxyurea-treated cells. Wild-type cells showed loss of cohesin 





chromosome arms. Although cells still passed through anaphase, about three-quarters of 
cells did not become viable during the following G1 phase due to chromosomes being cut 
or incompletely resolved.  Outwin et al. propose that the Smc5/6 complex affects 
chromosome dynamics by interacting with cohesin in either a direct or indirect way 

















Consequences of replication stress in Smc5/6 mutants 
Correlating with the requirement of Smc5/6 during HR-mediated repair and 
chromosome segregation, Smc5/6 mutants from yeast to man show robust evidence of 
replication stress. DNA damage during S-phase and G2 phase leads to checkpoint arrest 
that is stimulated by two kinases, Ataxia telangiectasia mutated (ATM) and ataxia 
telangiectasia and Rad3-related protein (ATR). ATM/ATR signaling is necessary to 
mediate DNA repair and reentry into mitosis (Shiloh, 2003). In budding yeast, ATR is the 
main checkpoint response that modulates S-phase progression. Under genotoxic stress, 
ATR delays replication origin firing, and leads to delayed S-phase entry (Putnam et al., 
2009). Smc6 mutants showed an ATR-dependent S-phase delay (Chen et al., 2013). 
Additionally, Nse2 was shown to be phosphorylated by ATR at serine 260 and 261, 
suggesting that ATR activation regulates Nse2-dependent DNA repair mechanisms 
(Carlborg et al., 2015).  
At the onset of DNA damage, ATR regulates another protein kinase, Chk1, which 
is essential for the G2/M damage checkpoint (Lui et al., 2000). In turn, Chk1 has been 
identified as one of the many proteins that can modify and regulate the tumor suppressor 
protein, p53 in response to DNA damage. p53 plays a major role in preserving genomic 
integrity by mediating stress-induced growth arrest or senescence (Ou et al., 2005). In 
human and mouse fibroblasts, p53 was shown to contribute to a checkpoint that ensures 
DNA is completely replicated before progressing into M-phase. Overexpression of p53 
inhibited mitotic entry even when cells were not stressed, suggesting that p53 modulates 
cell cycle progression (Taylor et al., 1999). To our knowledge, p53 has not been assessed 





ATR/Chk1 activity in Smc5/6 mutants, it is plausible that p53 is also being activated 
upon replication stress.  
In addition to altering signaling cascades, replication stress can also manifest as a 
cell shape deformity. Unreplicated, interwined, or tangled DNA can lead to the formation 
of anaphase bridges. Two types of DNA bridges have been noted in mammalian cells. 
One can be visualized by DAPI staining and is induced by HR-defective cells. The other 
type, known as ultrafine bridges, cannot be detected by DAPI. However, they can be 
immunostained for proteins involved in resolving bridge structures, such as PICH and 
BLM (Gelot et al., 2015). Both types of bridges have been found in Smc5/6 deficient 
cells (Gallego-Paez et al., 2014)  (Figure 6 A, B).  
Replication stress can also be transmitted to daughter cells. After cytokinesis, the 
formation of micronuclei has been observed (Figure 6 C). Micronuclei are aggregates of 
lagging chromosomes, acentric chromosomes, and chromatid fragments that are 
enveloped in their own nuclear membrane. Micronuclei can persist over several 
generations and undergo asynchronous replication (Gelot et al., 2015). Human cells 
deficient in proteins that resolve DNA bridges, such as FANCM and BLM, have shown a 
higher rate of micronuclei formation. Human cells deficient in NSE2 function have also 










Replication stress-induced DNA damage 
 
Figure 6 Examples of (A) DAPI stained bridges, (B) ultrafine bridges (Gallego-Paez, Tanaka et al., 2014) 



















Characterizing the effects of Smc5/6 depletion in mouse embryonic fibroblasts 
Thus far, Smc5/6 has largely been studied in lower organisms. In this study, we 
aimed to describe the role of Smc5/6 during mitosis in somatic mouse cells. We used a 
conditional knockout of Smc5 to characterize defects in immortalized mouse embryonic 
fibroblasts (MEF). Based on the implicated roles of the Smc5/6 complex during DNA 
damage repair and chromosome segregation, we hypothesized that Smc5/6 mutants 
would demonstrate multiple abnormalities during the cell cycle. We show evidence of 
replication stress via cell growth patterns, cell cycle analysis, immunostaining, and 
detection of elevated p53 levels. Additionally, we studied Rad51 accumulation and 




























Materials and Methods 
Mouse embryonic fibroblast (MEF) line derivation 
Heterozygous mice (Smc5+/del) were bred with mice homozygous for Cre-ERT2 to 
acquire the Cre recombinase transgene. Additionally, mice heterozygous for the flox 
allele (Smc5+/flox) were bred to obtain mice homozygous for the flox allele (Smc5flox/flox). 
Progeny of these mice were bred to obtain hemizygous Cre-ERT2 fetuses with Smc5flox/del 
(experimental) and Smc5+/flox (control #1) genotypes. 13.5 dpc fetuses with these 
genotypes were used to establish MEF lines. In addition, Smc5flox/del mice without the 
Cre-ERT2 transgene (control #2) were used to establish an additional control line (Figure 
7). 
For long-term studies, MEFs were immortalized according to the NIH-3T3 
protocol (Todaro et al., 1963). Primary mouse cells were passaged every three days until 
cells entered senescence. MEFs were monitored for regrowth and passaged until cells 
resumed a stable growth pattern (passage ~10-15). Cells were stored in liquid nitrogen in 
freezing medium (20% fetal bovine serum (FBS) (HyClone), 10% DMSO (Sigma), and 




























Cell culture conditions 
MEFs were cultured in DMEM (Invitrogen) supplemented with 10% FBS 
(Hyclone) and penicillin-streptomycin (100U/mL and 100g/mL) (Invitrogen). After 
thawing, cell growth was monitored for resumption of normal growth. MEFs took about 
3-5 days to achieve 80-90% confluency. Once cells became sub-confluent, MEFs were 
passaged every three days. Cells were washed twice with PBS (Invitrogen), and then 
treated with 0.05% trypsin-EDTA for 2-3 minutes for detachment. After neutralizing 
trypsin-EDTA with cell culture medium, cells were counted using a hemocytometer and 
replated at a density of 10,000 cells/cm2.  
The deletion in Smc5 gene was induced by treating experimental cells with 0.2M 
4-OH tamoxifen (Sigma H7904) (4-OH TAM). 4-OH TAM in cell culture medium was 
replenished every 2 days. MEFs were collected after 3, 6, and 9 days of 4-OH TAM 
treatment. Samples were washed with PBS, snap-frozen, and stored at -80ºC for further 
analysis.   
 
Polymerase chain reaction (PCR) analysis 
DNA was extracted using the Thermo Scientific GeneJet Genomic DNA 
purification kit. DNA concentration was measured using Nano-Drop (Fisher Scientific). 
50ng of DNA was used for each cell sample. Each PCR reaction contained a total volume 
of 50µL, consisting of 1x Taq polymerase buffer (5 Prime), 0.1mM dNTPs (5 Prime), 
2.5U Taq polymerase (5 Prime), and 0.1µM of each primer (Integrated DNA 





To assess genotypes, primer pairs 93 5’-ACTCAGTCTCACACGGCAAG-3’ 
(forward) and 83 5’-AGAAAGACATCAAACTAACCGCTGGC-3’ (reverse) were used 
to amplify wild type (410bp) and del (763bp) band fragments. For loxP sites, primer pairs 
93 (forward) and 94 5’-ATCCTTCCCACCTTGGAAAC-3’ (reverse) and 83 (reverse) 
and 84 5’-GAGATGGCGCAACGCAATTAAT-3’ (forward) were used. Product sizes 
were 563bp and 644bp respectively.  
The following PCR conditions were used: 
1. Denaturation: 90ºC for 1 min.  
2. Denaturation: 90ºC for 20 seconds. 
3. Annealing: 58ºC for 30 seconds. 
4. Amplification: 72ºC for 1 minute.  
5. Steps 2-4 were repeated for 30 cycles.  
6. Final extension: 72ºC for 10 minutes.  
 
After completion of PCR reaction, 20µL of each sample were resolved in 1.5% 
agarose gel. 
 
Western blot analysis 
Protein was extracted from cell samples by lysing 20,000 cells per 1µL of RIPA 
buffer (Santa Cruz) with 1x protease inhibitor (Roche) and 1x PhosSTOP phosphatase 
inhibitor (Roche). To remove cell debris, protein lysates were sonicated (Bioruptor 
sonication system) at high intensity for 5 minutes with 30 second on/off intervals, and 





tube and pellet was discarded. Protein concentration was measured using BCA assay kit 
(Pierce). 30µg of protein were used for analysis. Prior to loading, samples with added 
Laemmli buffer (Bio-Rad) were boiled at 95ºC for five minutes. 
For Smc5 and Smc6 protein detection we used 6.5% polyacrylamide homemade 
gels (Sambrook et al., 2001). For p53, 4-15% polycrylamide gradient gel (Bio-Rad) was 
used. All gels were run at 100V to resolve proteins. Proteins were transferred from gels 
onto a PVDF membrane (Bio-Rad) using TransBlot turbo system (Bio-Rad). After 
transfer, membranes were blocked in 3% bovine serum albumin (BSA) in PBS overnight.  
Primary antibodies were diluted in 3% BSA in PBS: rabbit anti-Smc5 (Bethyl, 
A300-236A) 1:400, rabbit anti-Smc6 (Abcam, ab155495) 1:400, rabbit anti-p53 (Santa 
Cruz, 6243) 1:200, rabbit anti-Acetyl-p53 (Cell Signaling, 2570) 1:1000, and mouse anti-
-tubulin (Sigma, T9026 ) 1:20,000. Secondary horseradish peroxidase conjugated-
antibodies goat anti-rabbit (Invitrogen, A10533) or rabbit anti-mouse (Invitrogen, 
R21455) were diluted 1:4000 in PBS. 
 Membranes were incubated with primary antibody for 1 hour, followed by two 
15 minute washes in rinse buffer (PBS + 0.1% Tween-20). Subsequently, secondary 
antibodies conjugated to horse radish peroxidase were added for 1 hour, followed by one 
15 minute wash and two 5 minute washes in rinse buffer. After final 5 minute wash in 
PBS, ECL (Thermo Scientific) was added to membranes in the dark for 1-2 minutes. 








Cell cycle analysis 
MEFs were plated at a density of 10,000 cells/cm2 onto tissue culture vessels and 
treated with 0.2µM 4-OH TAM for a total of 6 days. On Day 4 of 4-OH TAM treatment, 
cells were switched to low-serum medium (0.5% FBS) for 48 hours to induce cell cycle 
arrest in the G0/G1 phase. After washing once with PBS, cells were released from serum 
starvation by addition of regular cell culture medium (10% FBS). Cells were collected at 
0, 12, 15, 18, 21, and 24 hours after release (Figure 8). Collected cells were fixed by 
adding 3mL of 100% cold ethanol drop by drop to cell suspension in 1ml PBS. Cells 
were stored at -20ºC. 
 Twenty four hours before cell cycle analysis fixed MEFs were washed twice in 
4mL of cold PBS and centrifuged at 400g for 10 minutes. Cell pellet was resuspended in 
1mL of staining solution (PBS with 0.1% Triton X-100, 0.2mg/mL RNase A, and 
















FACS analysis scheme 
 
 


















MEF treatment schemes: cell synchronization and DNA damage agents 
MEFs were grown in cell culture vessel for 4 days and then plated onto sterile 
glass coverslips coated with 0.1% gelatin (Sigma). On Day 5, cells were treated 
according to the schemes below. Experimental MEFs were maintained in 0.2µM 4-OH 
TAM for the duration of the experiment. All cells were fixed with 10% formalin (Sigma) 
for 20 minutes at room temperature (RT), washed twice with PBS and stored at 4ºC in 
PBS. 
Nocodazole  
To observe anaphases, MEFs were synchronized in G2 phase of cell cycle using 
nocodazole (Cayman). Cells were treated with 0.1µg of nocodazole for 24 hours. After 
washing once with PBS, cells were released in nocodazole-free medium and fixed after 
45 minutes (Figure 9). 
 
Nocodazole treatment scheme 
 
 







Replication fork stalling was induced by treating cells with 2mM hydroxyurea 
(HU) (Sigma) for 24 hours. Following HU treatment, cells were synchronized in G2 
phase using 0.1µg nocodoazole for 24 hours. Cells were released in normal medium and 




Hydroxyurea treatment scheme 
 















Cells were treated for 6 days with 0.2M 4-OH TAM, followed by 24 hours with 
0.1µg nocodazole. Cells were released in normal medium for 2 hours to allow entry into 
mitosis. After entry, cells were treated with 15mM etoposide (Sigma) for 12 hours to 
block topoisomerase II activity and induce double strand breaks. After etoposide 
treatment, MEFs were released in normal medium for 12 hours to observe DNA damage 




Etoposide treatment scheme 
 
 













Prior to antibody staining, fixed cells were permeabilized with 0.1% Triton X-100 
(Sigma) for 10 minutes at RT, washed once in TBST (Sigma) wash buffer and blocked 
with 4% horse serum in PBS for 30 minutes at RT. Incubation with primary antibody was 
performed for 1 hour at RT, followed by 3 washes. Secondary antibodies conjugated with 
fluorophore were added for 1 hour in the dark. After 3 washes in the dark, cells were 
mounted onto super frosted microscope slides (Fisher) using mounting medium with 
DAPI (Vector Labs). 
Primary antibodies are as follows: rabbit anti-Rad51 (Thermo, PA527195) 1:100, 
mouse anti-SUMO1 (Matunis et al., 1996) 1:500, mouse anti-SUMO2/3 (Zhang et al., 
2008) 1:200, human anti-centromere (Antibodies incorporated, 15-235) 1:50, and mouse 
anti--tubulin (Sigma, T9026) 1:1000. Secondary antibodies raised against rabbit, mouse 
and human IgG and conjugated to Alexa 488, 568, and 633 (Life Technologies) were 
used at 1:3000 dilution. 
Image acquisition and processing 
Images were acquired using Zeiss Cell Observer Z1 linked to an ORCA-Flash 4.0 
CMOS camera (Hamamatsu) and analyzed with the Zeiss ZEN 2012 blue edition image 
software. Z stacks were acquired at 40x magnification with a region of interest (ROI) of 
512x512 pixels. Original images were processed by deconvolution for better clarity, and 
then a single image, which combined in focus light from each stack, was created using 
variance-based extended depth focusing. RAD51, SUMO1, and SUMO2/3 foci were 
counted using ImageJ by processing for image maxima. Photoshop (Adobe) was used to 






Conditional knockout of Smc5 in immortalized MEFs 
A Cre-flox system was used to obtain four MEF lines with the following genotypes: 
Smc5flox/del, Cre-ERT2 (Experimental #1 and #2), Smc5+/flox Cre-ERT2 (Control #1) and 
Smc5+/flox (Control #2). The Smc5 flox allele contains two loxP sites surrounding exon 4, 
while del allele has exon 4 deleted (Figure 12 A). The Cre-ERT2 recombinase was used to 
induce recombination between the loxP sequences, leading to excision of Smc5 exon 4 
(Figure 12 B). Exon 4 was chosen as a target because it has been identified in all Smc5 
transcripts. Additionally, the floxed exon is the 4th of 23, and is located early within the 
open reading frame. Therefore the mutation is likely to produce an unstable transcript, 
not capable of facilitating protein synthesis or a stable polypeptide. To induce Cre-ERT2 
recombinase expression, 0.2µM of 4-OH TAM was added to cell culture medium for 3, 6 
and 9 days.  
Deletion of exon 4 was confirmed by PCR. Primers pairs 93, 94, and 83, 84 
detected flox alleles with product sizes of 563bp and 644bp, respectively. Primers 93 and 
83 were used to detect del and wild type alleles with product sizes of 763bp and 410bp, 
respectively (Figure 12 A). Experimental lines showed a substantial decrease in flox 
alleles and an increase in del allele by Day 6. Control lines also showed a decrease in flox 
alleles while maintaining the wild type allele. Deletion was more efficient in control lines 
(Figure 13 A).  
Analogous to PCR results, western blot analysis showed partial depletion of Smc5 
and Smc6 by Day 3, and complete protein depletion by Day 9 (Figure 13 B). Decline in 





than as individual proteins. In the control line, we observed variable protein depletion 
after 9 days of 4-OH TAM treatment. It is possible that heterozygosity is causing a 
decline in protein levels. However, mice heterozygous for the Smc5 delete allele do not 
display any abnormal phenotypes, leading us to believe that this difference is 
insignificant. To further bypass this issue, we conducted all of our experiments after 6 






























Figure 12 (A) Scheme of Smc5 exon 4 deletion and primer positioning. Arrows (red) represent loxP sites. 
















Figure 13 (A) PCR genotyping of experimental and control. (B) Western Blot confirming Smc5 
and Smc6 depletion. Experimental and control cells were untreated (unt) or treated with 4-OH 








Smc5 mutants exhibit decreased cell proliferation and aberrant mitosis 
Analogous to PCR and western blot data, Smc5-depleted cells demonstrated 
abnormal cell growth. 4-OH TAM-treated experimental cells showed a sustained ~1.5-2 
fold decrease in cell growth by Day 6, while untreated experimental, untreated control, 
and 4-OH TAM-treated control cells demonstrated a consistent growth pattern (Figure 
14). Despite slower proliferation, 4-OH TAM-treated experimental cells did not show 
evidence of cell death.  All MEFs adhered to the cell culture vessel when plated, and did 
not display premature detachment.  
Immunofluorescence microscopy analysis also showed several mitotic aberrancies 
after 6 days of 4-OH TAM treatment. We observed an increased formation of 
micronuclei, DNA bridges and lagging chromosomes in Smc5-depleted cells (Figure 
15A-C). In comparison, untreated cells and 4-OH TAM-treated control cells showed 
significantly lower mitotic aberrancies. In addition, approximately 1 per 300 cells of the 
4-OH TAM-treated experimental cells contained supernumerary chromosomes, providing 





















Figure 15 (A, B) Three hundred interphase and anaphase cells were analyzed per condition for micronuclei 
and bridges/lagging chromosomes, respectively. Bar graphs show mean from three independent 
experiments. (C) DAPI staining of cells with micronuclei, bridges, and lagging chromosomes, denoted by 





Smc5 mutants demonstrate delayed entry into S-phase of cell cycle 
Based on observed cell growth characteristics, we hypothesized that Smc5-
depleted cells would demonstrate abnormalities in cell cycle progression. To investigate 
this, we performed FACS analysis. Cells were synchronized in the G0/G1 phase via 
serum starvation and then released in serum-containing culture medium (see methods 
Figure 8). S-phase entry began at 15 hours post-serum release and reached a peak at 18 
hours. Control #1 cells had 23% and 31% of cells in S-phase at 15 and 18 hours, 
respectively. After 4-OH TAM treatment, control #1 cells showed no appreciable 
differences (19% at 15 hours and 34% at 18 hours) (Figure 16 A, B). In control #2 cells, 
19% and 37% of cells were in S-phase after 15 hours and 18 hours, respectively. In line 
with previous reports, 4-OH TAM treatment increased cell cycle progression in control 
#2 cells (Abukhdeir et al., 2007). Twenty-seven percent and 48% of cells were in S-phase 
after 15 and 18 hours, respectively (Figure 16 C, D).  
In experimental MEFs, cell cycle progression was impeded after 4-OH TAM 
treatment. Similar to control cells, maximal number of cells were in S-phase 18 hours 
post-release. We did not observe a discernable difference in cell cycle progression 
between untreated and 4-OH TAM treated experimental #1 MEFs. At 18 hours, 27% and 
25% of cells were in S-phase for untreated and 4-OH TAM treated cells, respectively 
(Figure 17 A,B). However, 4-OH TAM treated experimental #1 cells had a smaller 
proportion of cells at 18 hours in S-phase compared to 4-OH TAM treated control #1 
cells (25% vs 34%, respectively). Experimental #2 cells demonstrated a delayed entry 
into S-phase. Untreated cells began entering S-phase at 15 hours post-serum release, 





cells entered S-phase, while only 19% of 4-OH TAM treated cells were in S-phase. 
Similarly, at 18 hours, 41% and 36% of untreated and 4-OH TAM treated cells were in S-
phase, respectively (Figure 17 C, D).  Despite differences in cell cycle dynamics, all cell 
lines still progressed to the G2 phase by 24 hours post-serum release.  
Even though 4-OH TAM treatment increased cell cycle progression in control 
lines, 4-OH TAM treated experimental cells still had fewer cells in S-phase at the peak S-
phase entry period of 18 hours. This suggests that the effect of 4-OH TAM was not 
enough to overcome Smc5 depletion. 4-OH TAM treated experimental #1 cells had 25% 
of cells in S-phase at 18 hours, while 4-OH TAM treated control #1 cells had 34% of 
cells in S-phase (Figure 18 A). Similarly, 4-OH TAM treated experimental #2 cells and 
4-OH TAM treated control #2 cells had 33% and 48% of cells in S-phase at 18 hours, 
respectively (Figure 18 B). Although differences were not statistically significant (p = 
0.1751), the trend we observe does suggest that Smc5 depletion is impacting cell cycle 
progression. Significant differences may arise upon treating cells with DNA damage 












FACS analysis: control cell lines 
 
 
Figure 16 FACS analysis of control cells. Control #1 cells were (A) untreated or (B) 4-OH TAM-treated. Control #2 cells were also (C) untreated or (D) 4-OH 





FACS analysis: experimental cell lines 
 
 
Figure 17 FACS analysis of experimental cells. Experimental #1 cells were (A) untreated or (B) 4-OH TAM-treated. Experimental #2 cells were also (C) 
untreated or (D) 4-OH TAM treated. Cells that were unable to be characterized are indicated as uncharacterized. Experiment was replicated three times and 







           
Figure 18 Percentage of cells in S-phase after 15, 18, and 21hours of serum release in (A) experimental #1 






Smc5 depletion leads to p53 accumulation 
 Decreased cell proliferation, chromosome segregation abnormalities and a 
delayed entry into S-phase suggest that Smc5 depleted cells were under mitotic stress. 
Based on these observations, we hypothesized that cells would be activating stress 
response pathways. We performed a western blot analysis to assess expression of the 
well-known stress response protein, p53. After 9 days of 4-OH TAM treatment, we found 
significant p53 accumulation in experimental cells, while control cells remained 
consistent (Figure 19). Experimental cells showed a 4.36 fold increase in p53 intensity 
before and after 9 days of 4-OH TAM treatment. In comparison, control cells only 









Figure 19 Western blot analysis of p53 expression in experimental and control MEF lines. Cells were 
either untreated (unt) or treated with 4-OH TAM for 3, 6, and 9 days (D3, D6, and D9, respectively). 







Smc5-depleted cells demonstrate heightened sensitivity to hydroxyurea and 
etoposide 
Previous studies in yeast have reported heightened sensitivity to DNA damage 
agents in SMC protein deficient cells in yeast (reviewed in Stephan et al., 2011). Our 
observations of p53 accumulation suggest that Smc5-depleted cells are activating a DNA 
damage checkpoint response. Paired with our observations of delayed S-phase entry and 
mitotic aberrancies, we hypothesized that cells are not undergoing efficient DNA 
replication. We used two DNA damage agents, hydroxyurea and etoposide, to determine 
whether Smc5-depleted cells would be able to successfully activate DNA damage repair 
mechanisms and maintain viability. Hydroxyurea inhibits ribonucleotide reductase, 
depleting dNTPs and ultimately causing replication fork stalling (Osterman et al., 2013). 
Etoposide was used to induce double strand DNA breaks by stabilizing a cleavable 
complex via topoisomerase II inhibition (Maanen et al., 1988). Double strand DNA 
breaks are considered to be lethal lesions when not repaired.     
 Similar to yeast, Smc5-depleted cells showed an increase in DNA damage when 
treated with HU. 4-OH TAM treated experimental #1 cells showed an increase in mitotic 
abnormalities when compared to untreated experimental #1, untreated control #1 and 4-
OH TAM treated control #1 cells (refer to Figure 8). Adding HU to cell culture for 24 
hours exacerbated mitotic aberrancies primarily among 4-OH TAM-treated experimental 
#1 cells. DAPI staining revealed a 9% increase in micronuclei formation, 8% increase in 
DNA bridges, and 16% increase in lagging chromosomes after HU treatment (Figure 20).  
 Treating Smc5-depleted cells with etoposide was much more devastating. After 





and then allowed to recover in etoposide-free medium for another 12 hours. Treating 
Smc5 deficient cells with etoposide caused several mitotic catastrophes. These events 
included more severe versions of missegregation events, micronuclei accumulation, DNA 
bridge formation, and lagging chromosomes. Twenty-four percent 4-OH TAM-treated 
experimental #1 cells showed one or more types of mitotic abnormalities. In comparison, 
only 8-14% of untreated experimental #1, untreated control #1 and 4-OH TAM-treated 
control #1 cells demonstrated mitotic aberrancies.  
Additionally, adding etoposide to cell culture caused cells to undergo nuclear 
fragmentation. Twenty-two to thirty percent of untreated experimental #1, untreated 
control #1, and 4-OH-TAM treated control #1 cells demonstrated nuclear fragmentation. 
In 4-OH TAM treated experimental #1 cells, almost 50% of 4-OH TAM treated cells 
























Figure 20 (A) Micronuclei formation and (B) anaphase bridges and lagging chromosome accumulation 
after hydroxyurea treatment. Three-hundred interphase and anaphase cells were analyzed in three 


















Figure 21 (A) Nuclear fragmentation and mitotic catastrophes were quantified in etoposide treated MEFs. 
Three-hundred cells were evaluated in three independent collections. Bar graphs represent mean. (B) DAPI 





Hydroxyurea treatment leads to increased Rad51 accumulation in Smc5-depleted 
MEFs 
In order to further characterize replication-related DNA repair pathways, we used 
immunostaining to investigate Rad51 accumulation. Replication fork stalling agents, such 
as hydroxyurea, induce activation of DNA damage repair pathways such as homologous 
recombination (HR) in order to promote cell survival. If replication forks are kept stalled, 
double strand DNA breaks may occur. Rad51 has been identified as key player in both 
HR and non-HR pathways (Peterman et al., 2010). For HR pathways, Rad51 mediates re-
start of replication forks by promoting single strand DNA stabilization and strand 
invasion. Additionally, it has been reported from studies using budding yeast and 
Drosophila melanogaster cell culture that Smc5/6 excludes Rad51 foci to prevent 
incorrect strand invasion and abnormal recombination specifically within 
heterochromatin enriched for repetitive DNA sequences (Eckert-Boulet et al., 2009; 
Chiolo et al., 2011).  
Because Smc5 mutants exhibited hypersensitivity to hydroxyurea treatment, we 
hypothesized that cells would be unable to undergo faithful HR and accumulate Rad51 
foci. MEFs were treated with hydroxyurea and allowed to recover in normal medium for 
25 hours. Despite the allowed recovery time, Smc5 mutants had ~44% increase in cells 
containing Rad51 foci compared to controls. Smc5-depleted cells averaged 40 foci per 
















Figure 22 (A) Rad51 foci in hydroxyurea-treated MEFs (n=25). (B) Samples of Rad51 accumulation in 







Smc5/6 depletion leads to a decrease in SUMO1 but not SUMO2/3 foci in 
hydroxyurea-treated cells 
Sumoylation has been cited as an important mechanism for DNA damage 
response and repair (Potts, 2009). In yeast, Nse2 mutations have been shown to cause a 
Rad51-dependent accumulation of X-shaped DNA structures (Branzei et al., 2006). It 
also been reported that SUMO noncovalently interacts with Rad51 at damaged 
replication forks to modulate HR (Ouyang et al., 2009). Based on this, we hypothesized 
that hydroxyurea-treated MEFs would show SUMO accumulation.  
We investigated both SUMO1 and SUMO2/3, and found differential expression. 
In hydroxyurea-treated MEFs, about 15-20% of untreated control cells, 4-OH TAM 
treated control cells and untreated experimental cells contained SUMO1 and SUMO2/3 
foci. 4-OH-TAM treated experimental cells showed a comparable number of SUMO2/3 
accumulation, but not SUMO1. Seven percent of Smc5 depleted MEFs exhibited 





















Figure 23 (A) Cells containing SUMO1 and SUMO2/3. Three-hundred cells were assessed in 3 






So far, the role of Smc5/6 has largely been studied in lower organisms. Only a 
few studies have used mouse and human models to elucidate the functionality of Smc5/6. 
In the handful of studies that did use mouse and human cells, siRNA was used to 
knockdown Smc5 and Smc6. This method, however, was found to cause off target 
effects. Therefore, previous findings suggesting that the Smc5/6 complex is required for 
maintenance of sister chromatid cohesion, together with suggestions that the Smc5 and 
Smc6 have independent functions are false (Wu et al., 2012). In this study, we used 
immortalized MEFs so that we could consistently manipulate cells and gain reproducible 
results. Though our model used a conditional knockout of Smc5, we observed a 
complimentary decline in Smc6 protein levels, suggesting that the entire Smc5/6 complex 
was destabilized.  
Unlike in fission and budding yeast cells, Smc5/6 is not essential for MEF 
viability. However, Smc5-depleted MEFs demonstrated a 1.5-2 fold decrease in 
proliferation compared to control cells. A similar trend was observed in a Smc5/6 
knockdown model in RPE-1 cells. At 5 days post-transfection with Smc5 siRNA, the cell 
number dropped by about half. Control cells proliferated to 15 million, while Smc5-
depleted cells only grew to only 8 million (Gallego-Paez et al., 2014). In chicken cells, a 
more drastic drop was observed. After 3 days, there were a total of 8 million wild type 
cells, and only 2 million Smc5 depleted cells (Stephan et al., 2011).   
 Decreased cell proliferation has been associated with compromised mitotic 
processes and replication stress (Gelot et al., 2015). We used immunofluorescence 
microscopy to visualize mitotic aberrancies. DAPI staining revealed an increase in DNA 





events in Smc5-depleted MEFs. These phenotypes have been consistently observed in 
other RNAi-mediated Smc5/6 knockdowns. In human RPE-1 Smc5 deficient cells, ~30% 
of cells accumulated anaphase bridges and lagging chromosomes (vs. 10% in controls). 
In MEFs we observed closer to 50% (vs. ~30% in controls) (Gallego-Paez et al., 2012). 
Compared to baseline levels, our cells demonstrated comparable results. Human NSE2 
mutants, however, had substantially lower micronuclei formation compared to our 
mutants MEFs. NSE2 mutants demonstrated ~6% micronuclei formation (Payne et al., 
2014), while our MEF Smc5 mutants showed almost 20%. Our MEFs may have shown 
higher micronuclei formation due to the entire complex being compromised, versus only 
a NSE2 mutation in human cells. Similar to our knockout MEFs, missegregation events, 
and lagging chromosomes were also observed in Smc5 depleted chicken cells (Stephan et 
al., 2011).  
Based on these observations, we next evaluated cell cycle progression. Similar to 
Smc6 mutants in budding yeast (Torres et al., 2007), our FACS analysis revealed that 
Smc5 depleted cells showed a delayed entry into S-phase, but still progressed to G2 
phase. In contrast, flow cytometry in chicken cells showed no difference in cell cycle 
distribution. Smc5 mutants and control cells had an equal amount of cells in G1, S, and 
G2-phase. However, Smc5-depleted chicken cells had a higher mitotic index than wild 
type cells. The ratio of cells entering mitosis vs. not entering mitosis was higher in Smc5-
depleted cells, suggesting impaired mitotic regulation. (Stephan et al., 2011). Other 
studies have shown that Smc5/6 mutants enter the cells cycle without completing DNA 
damage repair, leading to aberrant mitosis (Verkade et al., 1999; Harvey et al., 2004; 





observe accumulation of MEFs in G2 phase, Smc5-deficicent cells could be entering 
mitosis without repairing DNA damage. This further supports our observation of DNA 
bridges and lagging chromosomes.  
We also observed an upregulation of p53. p53 regulates several aspects of cell 
cycle processes. It inhibits re-replication after DNA damage by blocking S-phase entry. 
The p53 accumulation we observe parallels the delay in S-phase entry demonstrated in 
our FACS analysis. Additionally, p53 is important for the G2/M transition, and was 
shown to inhibit mitotic entry when DNA synthesis is blocked (Taylor et al., 1999). This 
could explain the overall slower cell growth observed in Smc5 mutants. To our 
knowledge, p53 has not been assessed in Smc5/6-deficient cells. 
Previous studies have shown Smc5/6 mutants to be hypersensitive to DNA 
damage agents both in lower organisms and mammalian models (reviewed in Stephan et 
al., 2011). Similarly, our Smc5 mutant cells showed heightened sensitivity to 
hydroxyurea and etoposide treatment. Both treatments lead to an increase in mitotic 
abnormalities (micronuclei, DNA bridges, lagging chromosomes, and missegregation) 
compared to controls. Additionally, ~50% of etoposide-treated cells underwent nuclear 
fragmentation, whereas only 20-30% of control cells displayed this phenomenon. This 
suggests that etoposide-induced DSBs may be creating insurmountable stress in Smc5-
depleted MEFs, further supporting Smc5’s crucial role in DNA damage repair.  
Based on observed hypersensitivity to DNA damage, we investigated DNA 
damage repair mechanisms. In yeast, Smc5/6 has been heavily implicated with HR-
mediated DNA damage repair during S-phase (reviewed in Wu and Ku et al., 2012). 





et al., 2008). In order to observe mitotic progression and recovery after replication fork 
stalling, we treated cells with hydroxyurea for 24 hours, and then synchronized them in 
HU-free medium for an additiona1 24 hours. Despite having 24 hours to recover, Smc5-
deficient MEFs showed an accumulation of Rad51 puncta. Our observation supports that 
Smc5 plays a role in HR-dependent repair pathways.  
In Drosophila melanogaster, it was suggested that Smc5/6 promotes expansion 
and relocalization of the damaged DNA segment to heterochromatin periphery in order to 
prevent abnormal Rad51-mediated recombination. Smc5/6 components localized to the 
HP1a domain during interphase and disassembled during mitosis (Chiolo et al., 2011). 
Similarly in S. pombe, Smc5/6 was shown to be recruited to pericentromeric 
heterochromatin after HU treatment, presumably for the repair of stalled replication forks 
(Pebernard et al., 2008). In our study, Rad51 puncta were not localized to 
heterochromatin. Therefore, we hypothesize that damaged DNA segments may be able to 
expand and relocalize outside of the heterochromatin domain for repair, but ultimately 
the recombination event cannot be resolved in the absence of the Smc5/6 complex. 
 Because we did not observe any nuclear fragmentation or cell death in HU-treated 
cells, we propose that MEFs are using other DNA damage repair mechanisms, such as 
NHEJ, to preserve cell viability. In yeast, it was shown that Smc5/6 plays an exclusive 
role in HR repair, and is not needed for NHEJ (De Piccoli, Cortes-Ledesma et al., 2006). 
Additionally, SUMOylation has been identified as an important post-translational 
modification in DNA damage repair mechanisms (Wu and Kong et al., 2012). SUMO1 
has been associated with HR and non-HR repair pathways, while SUMO2/3 is primarily 





in Smc5 mutants, but not SUMO2/3, suggests that Smc5/6 regulates or associates with 
SUMO function. This further supports that MEF Smc5 mutants are primarily deficient in 
HR-repair capabilities, similar to yeast mutants.  
 For the first time, we have validated the importance of Smc5 in mouse cells. Our 
data is consistent with many of the phenotypes observed in yeast, Drosophila, chicken, 
and human models. We are the first to show evidence of significant p53 upregulation, and 
differences in SUMO1 vs. SUMO2/3 modification. In addition, we have developed a 
model cell line that allows targeted mutation of a Smc5/6 component, which is not 
subject to off-target effects seen in previous work using siRNA knockdown. Future work 
should delineate other aspects of the p53 regulatory pathway to further characterize how 
Smc5 is impacting cellular stress response. Similarly, SUMO1 and SUMO2/3 

















Public Health Relevance 
Due to the widespread role of SMC complexes in the cell cycle, mutations in 
SMC proteins have been associated with rare, but severe developmental disorders. Two 
such disorders, Cornelia de Lange syndrome and Roberts’s syndrome, are associated with 
craniofacial abnormalities, mental retardation, limb defects, and gastrointestinal 
problems. Onset of symptoms can occur pre or post-natal, and are usually recognized 
early on from delayed growth patterns. Sixty-five percent of individuals affected with 
Cornelia de Lange syndrome show mutations in cohesin subunits Smc1, Smc3, and in the 
cohesin regulatory protein, NIPBL. Almost all cases have been identified as dominant 
and sporadic (Liu et al., 2010). In contrast, Roberts’s syndrome is inherited as an 
autosomal recessive trait. However, defects in Robert’s syndrome patients are also 
attributed to cohesin pathways. The establishment of cohesin 1 homolog 2 (ESCO2) 
protein was found to be disrupted, causing premature chromosome segregation primarily 
on chromosomes 1, 9, and 16 (Vega et al., 2010).  
Disorders caused by Smc5/6 mutations are less well characterized. However, 
similar devastating phenotypes have been observed in patients. Mutations in NSE2 have 
been associated with primordial dwarfism and microcephaly (Payne et al, 2014).  
Additionally, about 10% of sequenced cancers have been associated with mutations in the 
Smc5/6 subunits (Stevens et al, 2011). One hypothesis is that Smc5/6 mutation-induced 
stalled replication forks cause a pathological accumulation of X-shaped DNA structures, 
ultimately compromising genomic integrity, cell cycle progression and thus development 





Today, SMC-associated disorders have no cure. Furthermore, there still remains a 
large gap between SMC cell biology and the etiology of human diseases. SMC research 
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